about
Autoimmune Myopathies: Where Do We Stand?B-cell survival factors in autoimmune rheumatic disordersClinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.Investigating Idiopathic Inflammatory Myopathy; Initial Cross Speciality Experience with Use of the Extended Myositis Antibody Panel.Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.Myositis autoantibodies and clinical phenotypes.Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation.Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory MyopathiesThe CELF1 RNA-Binding Protein Regulates Decay of Signal Recognition Particle mRNAs and Limits Secretion in Mouse Myoblasts.Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseasesIdiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Autoimmunity versus autoinflammation--friend or foe?Galectin-3 in autoimmunity and autoimmune diseases.Expression of the autoantigen TRIM33/TIF1γ in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress.7-Tesla magnetic resonance imaging precisely and noninvasively reflects inflammation and remodeling of the skeletal muscle in a mouse model of antisynthetase syndrome.Muscle biopsies from human muscle diseases with myopathic pathology reveal common alterations in mitochondrial function.Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series.MDA-5 activation by cytoplasmic double-stranded RNA impairs endothelial function and aggravates atherosclerosis.Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.[Early symptoms of dermatomyositis and antisynthetase syndrome].The olfactory function is impaired in patients with idiopathic inflammatory myopathies.Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis.A Case of Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies.Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report.Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.Evolutionary gain of highly divergent tRNA specificities by two isoforms of human histidyl-tRNA synthetase.Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.Inflammatory Myopathy in Horses With Chronic Piroplasmosis.Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models.A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
P2860
Q26744554-364D65E6-C2DA-4830-87D1-85D8C5789A01Q26796484-461E470E-84EE-41FE-B382-5C217A83B503Q33670102-04D157AA-0C0F-4B91-AB3A-D2E5B0721CCDQ33691192-EC1795C9-E5E1-4731-8A01-6CC3C740E8DFQ35151003-6C5DF86E-38CE-4F81-A174-FB133CF3D5D5Q35153899-BFBA793C-281D-4A55-8B0B-A978FAD9F232Q35281962-9EAC4312-CAA2-410A-996C-306BE55FFD5FQ35281980-15A0BC9A-1B3E-4A70-96E8-F1EE959E1DA9Q35824298-768DA537-677C-4BC6-80C0-B97310F4F5ACQ36262468-1D7F1254-6D59-4AF4-B62E-082716CC24E1Q36424500-C52C204E-B70F-4FCD-949B-D159D268F850Q36439998-52B8A3EC-57D3-4146-87F2-511415B542A7Q37674765-58D1865B-DD6B-4BDA-BCED-ECD8CC753187Q38227340-1B28AC39-1AB5-4610-AB65-9D5E3BB33AFBQ38542678-E14BF62E-B09F-40C7-899A-3578A890B479Q38714316-51EFC789-37BC-43A7-BA92-175EB7E3E3DFQ39764555-AD7EA9A0-4F53-424F-BA4A-C49F8B30145AQ39888514-F71BA016-A6D2-4D16-847E-D08A50B00E7DQ40110267-D39ED07F-8EC8-4A67-8BAE-EE5217608657Q40775187-DB6FE394-D073-46C3-8F38-8A09635A6110Q40901486-2B51D271-AB2D-4C97-93B7-0BC0B453C6FFQ44276482-BD6F2273-E31B-4F6E-BBA0-7EE5FE81F441Q44920626-13C69BC8-BC50-40B7-95AD-A86EF689A35EQ48176876-7EB2763F-1BE9-42D8-9213-A85CC7A6BDB6Q48266675-8365A344-253E-4259-97D1-87259F091106Q48519769-A1BB8562-B652-4391-A65F-8D0FBDE84E4CQ49287962-377BB8AF-A9B3-462C-B02E-BBE0D02F51E9Q51090216-B5EB73BA-F59D-40B6-90BD-1AE5C7C705EFQ51092953-71F860C2-6374-4C9A-89ED-066929043FA1Q51280183-C888FA94-0675-42CE-8D7B-112C336A02FBQ52572936-54FE8BFA-C618-49B0-94CA-DEE0AD8F16A5Q52655916-F4DFF0F9-D21C-4CE1-8CCC-3D14158208D4Q53790402-FCC3F321-5AB8-4C99-8D3F-15FFFD87BE96Q58695117-72AFFE2E-5F38-4684-A433-3019505641BC
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Autoantibodies in polymyositis and dermatomyositis.
@en
type
label
Autoantibodies in polymyositis and dermatomyositis.
@en
prefLabel
Autoantibodies in polymyositis and dermatomyositis.
@en
P2093
P2860
P921
P1476
Autoantibodies in polymyositis and dermatomyositis.
@en
P2093
Anna Ghirardello
Elisabetta Borella
Lavinia Palma
Marta Domeneghetti
Nicola Bassi
P2860
P2888
P356
10.1007/S11926-013-0335-1
P577
2013-06-01T00:00:00Z
P5875
P6179
1045689715